Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Recent & Breaking News (NYSE:GSK)

New Research: Key Drivers of Growth for BP p.l.c, Petroleo Brasileiro S.A.- Petrobras, Transocean, GlaxoSmithKline plc, Noble, and Grupo Televisa S.A. — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire June 8, 2018

Adaptimmune Announces First Patient to Receive One Billion Target Cell Dose after Positive Safety Data from Pilot Study with MAGE-A4 SPEAR T-cells

GlobeNewswire June 4, 2018

Adaptimmune Presents Detailed Safety Update from Ongoing MAGE-A10 Pilot Studies at ASCO

GlobeNewswire June 4, 2018

Updated Myxoid/Round Cell Liposarcoma Data with NY-ESO, Presented at ASCO Annual Meeting, Further Supports Promising Benefit: Risk Profile

GlobeNewswire June 2, 2018

GSK Submits Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD

Business Wire May 29, 2018

Myxoid/Round Cell Liposarcoma Data with NY-ESO and MAGE-A10 Study Update to be Presented at American Association for Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 16, 2018

Adaptimmune Reports First Quarter 2018 Financial Results and Business Update

GlobeNewswire May 9, 2018

Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD

Business Wire April 24, 2018

Biotech Investors, Here's Your PDUFA Primer For October

Benzinga.com  September 28, 2017

GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing Single Inhaler Triple Therapy Trelegy Ellipta Reduced COPD Exacerbations

Business Wire September 20, 2017

Trelegy Ellipta Approved as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Appropriate Patients with COPD in the US

Business Wire September 18, 2017

Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Receives Positive Opinion from the CHMP in Europe for Appropriate Patients with COPD

Business Wire September 15, 2017

FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over

PR Newswire September 13, 2017

Positive Results from Pioneering Salford Lung Study in Asthma Published in The Lancet, and Presented at European Respiratory Congress

Business Wire September 11, 2017

GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO

GlobeNewswire September 7, 2017

Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts

Benzinga.com  September 1, 2017

Technical Reports on Drug Makers Equities -- Impax Labs, GlaxoSmithKline, Novartis, and TherapeuticsMD

PR Newswire August 29, 2017

Where Does Zika Virus Vaccine Research Stand Now?

Benzinga.com  August 12, 2017

August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty

Benzinga.com  August 1, 2017

ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings

PR Newswire July 25, 2017